"Minneapolis VA Health Care System is a teaching hospital providing a full range of patient care services with state-of-the-art technology, as well as education and research. Comprehensive health care is provided through primary care, tertiary care and long-term care in areas of medicine, surgery, psychiatry, physical medicine and rehabilitation, neurology, oncology, dentistry, geriatrics and extended care. The Minneapolis VA Health Care System provides for the health care needs of Veterans in Minnesota and Western Wisconsin."

During the past decade, Veterans Affairs Medical Center - Minneapolis conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 92 clinical trials were completed, i.e. on average, 76.7% percent of trials that started reached the finish line to date. In the past 5 years, 48 clinical trials started and 34 clinical trials were completed. i.e. 70.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Veterans Affairs Medical Center - Minneapolis" #1 sponsor was "VA Office of Research and Development" with 85 trials, followed by "Alliance for Clinical Trials in Oncology" with 69 trials sponsored, "US Department of Veterans Affairs" with 43 trials sponsored, "National Cancer Institute (NCI)" with 37 trials sponsored and "Minneapolis Veterans Affairs Medical Center" with 37 trials sponsored. Other sponsors include 124 different institutions and companies that sponsored additional 72 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Veterans Affairs Medical Center - Minneapolis" #1 collaborator was "National Cancer Institute (NCI)" with 113 trials as a collaborator, "Minneapolis Veterans Affairs Medical Center" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 13 trials as a collaborator and "SWOG Cancer Research Network" with 13 trials as a collaborator. Other collaborators include 211 different institutions and companies that were collaborators in the rest 156 trials.

According to Clinical.Site data, the most researched conditions in "Veterans Affairs Medical Center - Minneapolis" are "Lung Cancer" (21 trials), "Colorectal Cancer" (16 trials), "Leukemia" (14 trials), "Lymphoma" (13 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "Veterans Affairs Medical Center - Minneapolis" in a lesser frequency.

Most popular intervention types in "Veterans Affairs Medical Center - Minneapolis" are "Drug" (207 trials), "Other" (85 trials), "Biological" (55 trials), "Behavioral" (54 trials) and "Procedure" (54 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (14 trials), "carboplatin" (13 trials) and "cyclophosphamide" (12 trials). Other intervention names were less common.

The vast majority of trials in "Veterans Affairs Medical Center - Minneapolis" are 364 trials for "All" genders, 25 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 100 active trials in "Veterans Affairs Medical Center - Minneapolis". 5 are not yet recruiting, 48 are recruiting, 43 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 238 completed trials in Veterans Affairs Medical Center - Minneapolis, 2 suspended trials, and 39 terminated clinical trials to date.

Out of the total trials that were conducted in Veterans Affairs Medical Center - Minneapolis, 15 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 21 trials, and there were also 119 trials that are defined as “Not Applicable".